Cargando…
Antibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with ‘seronegative’ antiphospholipid syndrome
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283613/ https://www.ncbi.nlm.nih.gov/pubmed/25359383 http://dx.doi.org/10.1136/annrheumdis-2014-206483 |
_version_ | 1782351287612866560 |
---|---|
author | Cousins, Laura Pericleous, Charis Khamashta, Munther Bertolaccini, Maria Laura Ioannou, Yiannis Giles, Ian Rahman, Anisur |
author_facet | Cousins, Laura Pericleous, Charis Khamashta, Munther Bertolaccini, Maria Laura Ioannou, Yiannis Giles, Ian Rahman, Anisur |
author_sort | Cousins, Laura |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4283613 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-42836132015-01-08 Antibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with ‘seronegative’ antiphospholipid syndrome Cousins, Laura Pericleous, Charis Khamashta, Munther Bertolaccini, Maria Laura Ioannou, Yiannis Giles, Ian Rahman, Anisur Ann Rheum Dis Letters BMJ Publishing Group 2015-01 2014-10-30 /pmc/articles/PMC4283613/ /pubmed/25359383 http://dx.doi.org/10.1136/annrheumdis-2014-206483 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/ |
spellingShingle | Letters Cousins, Laura Pericleous, Charis Khamashta, Munther Bertolaccini, Maria Laura Ioannou, Yiannis Giles, Ian Rahman, Anisur Antibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with ‘seronegative’ antiphospholipid syndrome |
title | Antibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with ‘seronegative’ antiphospholipid syndrome |
title_full | Antibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with ‘seronegative’ antiphospholipid syndrome |
title_fullStr | Antibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with ‘seronegative’ antiphospholipid syndrome |
title_full_unstemmed | Antibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with ‘seronegative’ antiphospholipid syndrome |
title_short | Antibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with ‘seronegative’ antiphospholipid syndrome |
title_sort | antibodies to domain i of β-2-glycoprotein i and iga antiphospholipid antibodies in patients with ‘seronegative’ antiphospholipid syndrome |
topic | Letters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283613/ https://www.ncbi.nlm.nih.gov/pubmed/25359383 http://dx.doi.org/10.1136/annrheumdis-2014-206483 |
work_keys_str_mv | AT cousinslaura antibodiestodomainiofb2glycoproteiniandigaantiphospholipidantibodiesinpatientswithseronegativeantiphospholipidsyndrome AT pericleouscharis antibodiestodomainiofb2glycoproteiniandigaantiphospholipidantibodiesinpatientswithseronegativeantiphospholipidsyndrome AT khamashtamunther antibodiestodomainiofb2glycoproteiniandigaantiphospholipidantibodiesinpatientswithseronegativeantiphospholipidsyndrome AT bertolaccinimarialaura antibodiestodomainiofb2glycoproteiniandigaantiphospholipidantibodiesinpatientswithseronegativeantiphospholipidsyndrome AT ioannouyiannis antibodiestodomainiofb2glycoproteiniandigaantiphospholipidantibodiesinpatientswithseronegativeantiphospholipidsyndrome AT gilesian antibodiestodomainiofb2glycoproteiniandigaantiphospholipidantibodiesinpatientswithseronegativeantiphospholipidsyndrome AT rahmananisur antibodiestodomainiofb2glycoproteiniandigaantiphospholipidantibodiesinpatientswithseronegativeantiphospholipidsyndrome |